AnalystsUmer RaffatUmer Raffat's Stock Forecasts
AnalystsUmer Raffat
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#4005 out of 4560 analysts
Average Return
-13.72%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Umer Raffat's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | +75.77% | $22.41 | $39.39 | 2022-02-02 - 2023-02-01 | Buy |
Legend Biotech CorpLEGN | +32.22% | $50.53 | $66.81 | 2022-11-02 - 2023-11-01 | Buy |
Dicerna Pharmaceuticals IncDRNA | +23.35% | $8.65 | $10.67 | 2018-01-16 - 2019-01-16 | Buy |
Organon & CoOGN | +19.98% | $30.33 | $36.39 | 2021-06-10 - 2022-06-09 | Buy |
Jazz Pharmaceuticals PLCJAZZ | +8.91% | $135.40 | $147.46 | 2017-02-23 - 2018-02-23 | Strong Buy |
Umer Raffat Analyst Color
Get additional color on Umer Raffat's coverage of popular stocks
Umer Raffat's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Legend Biotech CorpLEGN | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Phathom Pharmaceuticals IncPHAT | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Amylyx Pharmaceuticals IncAMLX | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Organon & CoOGN | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Kodiak Sciences IncKOD | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Vor Biopharma IncVOR | 1 | Buy | $48.00 | N/A | Initiates Coverage On | 3 years ago |
Amgen IncAMGN | 1 | Buy | N/A | N/A | Upgrades | 4 years ago |
Pieris Pharmaceuticals IncPIRS | 1 | Buy | $1,040.00 | N/A | Initiates Coverage On | 6 years ago |
Dicerna Pharmaceuticals IncDRNA | 1 | Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Dermira IncDERM2 | 1 | Buy | $48.00 | N/A | Initiates Coverage On | 7 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.